Consumption of dietary supplements containing Citrus aurantium (Bitter orange) - 2004 California Behavioral Risk Factor Surveillance Survey (BRFSS)

Annals of Pharmacotherapy

Volumn 40, Issue 10, 2006, Pages 1747-1751

  Klontz, Karl C ^a   Timbo, Babgaleh B ^a   Street, Debra ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Bitter orange; Citrus aurantium; Dietary supplements

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALKALOID; EPHEDRA EXTRACT; OXEDRINE;

ADULT; AGED; ALCOHOL CONSUMPTION; BODY MASS; CALIFORNIA BEHAVIORAL RISK FACTOR SURVEILLANCE SURVEY; DEMOGRAPHY; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFECT; ENERGY; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HERB; HIGH RISK POPULATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; SOUR ORANGE; UNITED STATES; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; APPETITE REGULATION; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CALIFORNIA; CITRUS; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SOCIOECONOMIC FACTORS; WEIGHT LOSS;

EID: 33749598329     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H196     Document Type: Review

References (12)

1. US Food and Drug Administration. FDA announces plans to prohibit sales of dietary supplements containing ephedra (news release). Rockville, MD: Department of Health and Human Services, US Food and Drug Administration, Dec 30,2003. www.hhs.gov/news/pres/2003pres/20031230.html (accessed 2006 Feb 12).
2. Kaufmann DW, Kelly JP, Mitchell AA. Use of ephedra-containing products in the US population. Slone survey 2003. FDA docket number 1995N-0303, emcl26, vol. 297:1-9
3. Allison DB, Cutter G, Poehlman ET, Moore DR, Barnes S. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain? Int J Obesity 2005;29:443-6.
4. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. Operational and User's Guide. Version 3.0. Atlanta, GA: Centers for Disease Control and Prevention, Mar 4, 2005. www.cdc.gov/brfss/pubs/ index.htm#users (accessed 2006 Jan 19).
5. RTI International. SUDAAN user's manual: professional software for survey data analysis. SUDAAN release 9.0.1. Research Triangle Park, NC: RTI International, 2005.
6. Blanck HM, Khan LK, Serdula MK. Use of nonprescription weight loss products: results from a multistate survey. JAMA 2001;286:930-5.
7. Block G, Cox C, Madans J, Schreiber GB, Licitra L, Melia N. Vitamin supplement use, by demographic characteristics. Am J Epidemiol 1988;127:297-309.
8. Moss A, Levy A, Kim I, Park Y. Use of vitamin and mineral supplements in the United States: current users, types of products, and nutrients. Hyattsville, MD: Advance Data No.174 from Vital and Health Statistics of the National Center for Health Statistics, 1989.
9. Slesinski MJ, Subar A, Kahle L. Trends in the use of vitamin and mineral supplements in the United States: the 1987 and 1992 National Health Interview Surveys. J Am Diet Assoc 1995;95:921-3
10. Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc 2004;104:942-50.
11. Radimer KL, Subar AY, Thompson FE. Nonvitamin, nonmineral dietary supplements: issues and findings from NHANES III. J Am Diet Assoc 2000;100:447-54.
12. Bouchard NC, Howland MA, Greller HA, Hoffman RS, Nelson LS. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine. Mayo Clin Proc 2005;80:541-5.